Latest News about MRK
Recent news which mentions MRK
From Benzinga
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%
November 26, 2021
Tickers
MRK
From Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
From Benzinga
Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer
November 23, 2021
Tickers
MRK
From Benzinga
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
November 23, 2021
From Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
From Benzinga
Will Investors Benefit From Johnson & Johnson's Breakup?
November 23, 2021
From Motley Fool
Orally Administered Covid-19 Treatment Should Bolster Merck’s Value
November 22, 2021
Tickers
MRK
From InvestorPlace
3 Falling-Star Stocks to Buy Into the Holidays
November 22, 2021
From InvestorPlace
Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year
November 22, 2021
From InvestorPlace
From Motley Fool
Is Merck Stock a Buy?
November 20, 2021
From Motley Fool
EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness
November 19, 2021
Tickers
MRK
From Benzinga
Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention
November 19, 2021
From MarketWatch
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
From InvestorPlace
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
November 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
Skipping Eye Exams Linked to Nearly 6 Million Cases of Preventable Vision Loss, According to Vision Care Experts
November 19, 2021
From Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting
November 18, 2021
Tickers
MRK
From Benzinga
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
From Benzinga
From Motley Fool
From Benzinga
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.